Terms: = Lymphoma AND PPM1D, Wip1, 8493, ENSG00000170836, O15297, WIP1, PP2C-DELTA AND Treatment
6 results:
1. Low-Frequency
Seipel K; Frey M; Nilius H; Akhoundova D; Banz Y; Bacher U; Pabst T
Curr Oncol; 2023 Dec; 30(12):10463-10476. PubMed ID: 38132396
[TBL] [Abstract] [Full Text] [Related]
2. Allosteric wip1 phosphatase inhibition through flap-subdomain interaction.
Gilmartin AG; Faitg TH; Richter M; Groy A; Seefeld MA; Darcy MG; Peng X; Federowicz K; Yang J; Zhang SY; Minthorn E; Jaworski JP; Schaber M; Martens S; McNulty DE; Sinnamon RH; Zhang H; Kirkpatrick RB; Nevins N; Cui G; Pietrak B; Diaz E; Jones A; Brandt M; Schwartz B; Heerding DA; Kumar R
Nat Chem Biol; 2014 Mar; 10(3):181-7. PubMed ID: 24390428
[TBL] [Abstract] [Full Text] [Related]
3. wip1 and p53 contribute to HTLV-1 Tax-induced tumorigenesis.
Zane L; Yasunaga J; Mitagami Y; Yedavalli V; Tang SW; Chen CY; Ratner L; Lu X; Jeang KT
Retrovirology; 2012 Dec; 9():114. PubMed ID: 23256545
[TBL] [Abstract] [Full Text] [Related]
4. Costs of drug delivery for CHOP, COP/CVP, and fludarabine: an international assessment.
Herold M; Hieke K
Value Health; 2003; 6(2):167-74. PubMed ID: 12641867
[TBL] [Abstract] [Full Text] [Related]
5. Therapeutic trial for infant acute lymphoblastic leukemia: the Pediatric Oncology Group experience (POG 8493).
Frankel LS; Ochs J; Shuster JJ; Dubowy R; Bowman WP; Hockenberry-Eaton M; Borowitz M; Carroll AJ; Steuber CP; Pullen DJ
J Pediatr Hematol Oncol; 1997; 19(1):35-42. PubMed ID: 9065717
[TBL] [Abstract] [Full Text] [Related]
6. [Acute lymphoblastic leukemia in infants--results of treatment according to infant leukemia protocol--POG 8493].
Sońta-Jakimczyk D; Armata J; Bogusławska-Jaworska J; Cyklis R; Chybicka A; Grześkowiak-Melanowska J; Radwańska U; Swiatły A; Wieczorek M
Acta Haematol Pol; 1993; 24(2):131-8. PubMed ID: 8372612
[TBL] [Abstract] [Full Text] [Related]
